Sun Pharmaceutical Industries was hit with a patent infringement lawsuit on July 9 in New Jersey District Court over its attempt to market generic versions of the antipsychotic drug Invega Sustenna.
Janssen sued Teva in the US District Court for the District of New Jersey under the Hatch-Waxman Act after Teva filed an abbreviated new drug application (ANDA) on a generic version of Invega Sustenna ...
TITUSVILLE, N.J., April 3, 2017 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an ...
“The CAFC first explained that the case law on presumption of obviousness due to overlapping numerical ranges between the patent at issue and the prior art did not support applying the presumption in ...
Our Case of the Week focuses on obviousness. More particularly, the decision included a lengthy discussion on a so-called “presumption” of obviousness that has been invoked in cases involving ...
VitalConnect and physIQ are teaming up with the Haga Teaching Hospital in the Netherlands to conduct a study on how wearable biosensors and artificial intelligence can augment care for cancer patients ...
A better understanding of early childhood microbiome shifts offers a unique window for detecting disease risk and intervening appropriately. In this webinar, Lloyd Bod and Nathaniel Robichaud will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback